Enhancer landscape in CLL upon BTK inhibition

Press/Media: Research

Description

Efterpi Kostareli, PhD, Queen's University Belfast, Belfast, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. She discusses the enhancer landscape in chronic lymphocytic leukemia (CLL) upon BTK inhibition. Using pre and post ibrutinib treatment CLL patient samples, a longitudinal analysis of global post-translational modifications (PTMs) revealed significant heterogeneity between patients and time points.

Period03 Apr 2019

Media contributions

1

Media contributions

  • TitleEnhancer landscape in CLL upon BTK inhibition
    Degree of recognitionInternational
    Media name/outletVJHemOnc – Video Journal of Hematological Oncology
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date03/04/2019
    Description VJHemOnc – Video Journal of Hematological Oncology
    Efterpi Kostareli, PhD, Queen's University Belfast, Belfast, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. She discusses the enhancer landscape in chronic lymphocytic leukemia (CLL) upon BTK inhibition. Using pre and post ibrutinib treatment CLL patient samples, a longitudinal analysis of global post-translational modifications (PTMs) revealed significant heterogeneity between patients and time points.
    URLhttps://www.youtube.com/watch?v=TGUuQH_7yTg
    PersonsEffie Kostareli
View all 1
View less

Related content